Join to view full profile
165 Somerset StreetNew Brunswick, NJ 08901
Dr. Hinrichs is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2014
George Washington UniversityResidency, Internal Medicine, 2009 - 2010
University of Missouri Kansas City School of MedicineClass of 1996
Certifications & Licensure
NJ State Medical License 2020 - 2027
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols Start of enrollment: 2016 Apr 11
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers Start of enrollment: 2017 Jan 27
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers Start of enrollment: 2025 Aug 11
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsImpact of vector copy number on critical quality attributes of retrovirally engineered T cells.Scott M Norberg, Rupali Gund, Ekaterina Doubrovina, Stacey L Doran, Tatyana Fuksenko
Molecular Therapy. 2026-04-01 - 9 citationsGPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma.Reona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, Taisuke Kondo, Jangsuk Oh
Cancer Immunology Research. 2025-09-02 - 4 citationsRespiration defects limit serine synthesis required for lung cancer growth and survival.Eduardo Cararo Lopes, Fuqian Shi, Akshada Sawant, Maria Ibrahim, Maria Gomez-Jenkins
Nature Communications. 2025-08-15
Press Mentions
Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-Term Complete Responses of T Cell Therapies for HPV-Related CancersNovember 10th, 2025- Health Insurance Company Rules Are Costing Some Cancer Patients Their LivesAugust 7th, 2025
- Here’s How Trump and Oz Can Fix MedicareMay 5th, 2025
Grant Support
- Expanding the Reach of TCR-T Therapies for HPV16-Associated Cancers Beyond HLA-A*02:01RUTGERS BIOMEDICAL AND HEALTH SCIENCES2026–2031
- E7 TCR-T cell therapy for HPV-associated cancersRUTGERS BIOMEDICAL AND HEALTH SCIENCES2024–2028
- The Landscape of Tumor intrinsic Genetic Resistance to T cell TherapyRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2026
- The Landscape of Tumor intrinsic Genetic Resistance to T cell TherapyRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2026
- Developing TCR-T cell therapy in renal cell carcinomaRUTGERS BIOMEDICAL AND HEALTH SCIENCES2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
